UY39388A - Nuevos compuestos que se unen al receptor nr 1 h4 (fxr) y actúan como antagonistas de fxr4 - Google Patents
Nuevos compuestos que se unen al receptor nr 1 h4 (fxr) y actúan como antagonistas de fxr4Info
- Publication number
- UY39388A UY39388A UY0001039388A UY39388A UY39388A UY 39388 A UY39388 A UY 39388A UY 0001039388 A UY0001039388 A UY 0001039388A UY 39388 A UY39388 A UY 39388A UY 39388 A UY39388 A UY 39388A
- Authority
- UY
- Uruguay
- Prior art keywords
- fxr4
- fxr
- antagonists
- act
- new compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161507153P | 2011-07-13 | 2011-07-13 | |
EP11005722A EP2545964A1 (en) | 2011-07-13 | 2011-07-13 | Novel FXR (NR1H4) binding and activity modulating compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
UY39388A true UY39388A (es) | 2021-09-30 |
Family
ID=62454900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001039388A UY39388A (es) | 2011-07-13 | 2021-08-18 | Nuevos compuestos que se unen al receptor nr 1 h4 (fxr) y actúan como antagonistas de fxr4 |
Country Status (4)
Country | Link |
---|---|
JP (3) | JP2018123152A (ja) |
HK (2) | HK1244682A1 (ja) |
IL (3) | IL253437A0 (ja) |
UY (1) | UY39388A (ja) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002532729A (ja) * | 1998-12-23 | 2002-10-02 | グラクソ グループ リミテッド | 核内受容体のリガンドのアッセイ |
CL2007001451A1 (es) * | 2006-05-24 | 2008-01-11 | Eli Lilly And Company Soc Organizada Bajo Las Leyes Del Estado De Indiana | Compuestos derivados de [1,2,3]-tiazol-4-ilmetoxilo, agonista del receptor farnesoide x (fxr); composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dislipidemia y enfermedades relacionadas. |
EP1894924A1 (en) * | 2006-08-29 | 2008-03-05 | Phenex Pharmaceuticals AG | Heterocyclic FXR binding compounds |
EP2289883A1 (en) * | 2009-08-19 | 2011-03-02 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
EP2545964A1 (en) * | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
-
2017
- 2017-07-12 IL IL253437A patent/IL253437A0/en active IP Right Grant
-
2018
- 2018-03-26 HK HK18104110.7A patent/HK1244682A1/zh unknown
- 2018-04-04 JP JP2018072746A patent/JP2018123152A/ja active Pending
- 2018-05-18 HK HK18106486.8A patent/HK1246716A1/zh unknown
-
2019
- 2019-04-11 IL IL265973A patent/IL265973B/en active IP Right Grant
- 2019-08-26 JP JP2019153457A patent/JP6878526B2/ja active Active
-
2020
- 2020-09-24 IL IL277570A patent/IL277570A/en unknown
-
2021
- 2021-03-05 JP JP2021035272A patent/JP2021091727A/ja not_active Withdrawn
- 2021-08-18 UY UY0001039388A patent/UY39388A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2018123152A (ja) | 2018-08-09 |
HK1246716A1 (zh) | 2018-09-14 |
JP2019214611A (ja) | 2019-12-19 |
HK1244682A1 (zh) | 2018-08-17 |
IL277570A (en) | 2020-11-30 |
IL265973A (en) | 2019-06-30 |
IL265973B (en) | 2020-10-29 |
JP2021091727A (ja) | 2021-06-17 |
JP6878526B2 (ja) | 2021-05-26 |
IL253437A0 (en) | 2017-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2021505I1 (lt) | Pakeistojo policiklinio karbamoilpiridono darinio provaistas | |
CR20140305A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de transtornos inflamatorios | |
CR20140510A (es) | Nucleósidos de espirooxetano de uracilo | |
CY1119345T1 (el) | Μακροκυκλικες ενωσεις ως αναστολεις κινασης trk | |
CR20140042A (es) | Indazoles | |
CR20130369A (es) | Novedosos derivados heterocíclicos | |
CR20130470A (es) | INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA | |
CR20130419A (es) | Derivados heterocíclicos de amina | |
CR20130537A (es) | Compuestos heterocíclicos como inhibidores de cinasas | |
CR20140030A (es) | 4-imidazopiridazin-1-il-benzamidas y 4-imidazotriazin-1-il-benzamidas como inhibidores de btk | |
CR20140132A (es) | Derivados de pirrolopirimidina y purina | |
CR20130233A (es) | Derivados que quinazolin-4 (3h)-ona utilizados como inhibidores de pi3 cinaza | |
CO6831982A2 (es) | Pirazolo[4,3-d]pirimidinas útiles como inhibidores de cinasas | |
UY34825A (es) | Síntesis de compuestos heterocíclicos | |
UY34798A (es) | Polipéptidos de unión a receptores de quimiocinas | |
CR20150271A (es) | Peptidos como agonistas de oxitocina | |
CR20140535A (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
CR20130087A (es) | Compuestos de espiropiperidina como antagonistas del receptor orl-1 | |
CR20120513A (es) | HETEROARIL-CICLOHEXIL-TETRAAZABENZO [e] AZULENOS | |
CR20140094A (es) | Derivados de etinilo | |
CR20140322A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 | |
CR20150084A (es) | 2-oxo-2,3-dihidro-indoles | |
CL2014000436A1 (es) | Composiciones de detergentes para la ropa que comprenden agentes antiadherente de tierra | |
CR20130475A (es) | Derivados de etinilo | |
CO7151499A2 (es) | Formulación inyectable |